Advertisement.

RZLTD Projected Dividend Yield

Rezolute Inc ( OTCBB : RZLTD )

Rezolute is a clinical stage biotechnology company developing therapies targeting rare and metabolic diseases. Co.'s primary pipeline, RZ358 is a fully human, monoclonal antibody that has been designed to treat all forms of Congenital Hyperinsulinism, as well as potentially other indications. RZ402 is a therapy for Diabetic Macular Edema and has been shown to normalize retinal vascular permeability in clinically-relevant animal models of macular edema. AB101 is an extended release microsphere formulation of PEGylated human recombinant insulin. It is being developed as a once-weekly subcutaneous injection to improve glycemic control in patients with Type 1 and Type 2 Diabetes Mellitus.

20 YEAR PERFORMANCE RESULTS

RZLTD Dividend History Detail
RZLTD Dividend News
RZLTD Competitors News

# of Shares: 0

Closing Price: 20.51

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000